Return To Full Article
You can republish this story for free. Click the "Copy HTML" button below. Questions? Get more details.

Effective but Underprescribed: HIV Prevention Meds Aren’t Reaching Enough People

Listen: More than 2 million Americans could benefit from PrEP, but only about a quarter of them are getting the HIV prevention medication. On Feb. 4, during WAMU’s “Health Hub,” KFF Health News reporter Zach Dyer shared tips for overcoming common hurdles to care.

Billing mistakes. Stigma. Doctors who aren’t keeping up with the latest research. Those are just some of the hurdles that keep HIV prevention medication out of reach for many Americans.

The Centers for Disease Control and Prevention estimates more than 2 million Americans could benefit from a treatment known as PrEP, but only a quarter of them are getting a form of the drug. Zach Dyer appeared on WAMU’s “Health Hub” on Feb. 4 to share tips patients can use to avoid those pitfalls and find a doctor who knows more about PrEP.

KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the core operating programs at KFF—an independent source of health policy research, polling, and journalism. Learn more about KFF.

Help KFF Health News track this article

By including these elements when you republish, you help us:
  • Understand which communities and people we’re reaching.
  • Measure the impact of our health journalism.
  • Continue providing free, high-quality health news to the public.
Canonical Tag

Include this in your page's <head> section to properly attribute this content.

Tracking Snippet

Add this snippet at the end of your republished article to help us track its reach.